JenLab
Neueng├╢nna
About JenLab
JenLab GmbH provides femtosecond laser technology for medicine, biotechnology and cell biology use. Clinical in vivo optical biopsies with subcellular spatial resolution and chemical information based on near infrared femtosecond laser technology can be obtained with the CE marked Multiphoton Tomographs DermaInspect, the SPIE Prism awarded MPTflex and MPTflex CARS.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.8M
- Last round: Grant (Sep 2016)
- Website: jenlab.de
Industries & Categories
Biotechnology, Hospital, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/jenlab-169060 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.